Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: A double-blind, placebo-controlled study

Menopause

Volumn 9, Issue 1, 2002, Pages 65-71

  Cagnacci, Angelo ^a   Malmusi, Stefania ^a   Arangino, Serenella ^a   Zanni, Annalisa ^a   Rovati, Lucio ^a   Cagnacci, Paolo ^a   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Body mass index; Estrogens; Insulin; Leptin; Menopause

Indexed keywords

ESTRADIOL; LEPTIN; PLACEBO;

ADULT; ARTICLE; BIOENERGY; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WATER CONTENT;

EID: 0036156438     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200201000-00010     Document Type: Article

References (48)

1. Leptin is released from the human brain: Influence of adiposity and gender
2. Leptin and clinical medicine: A new piece in the puzzle of obesity
3. Identification and expression cloning of a leptin receptor, OB-R
4. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
5. Evidence of free and bound leptin in human circulation: Studies in lean and obese subjects and during short-term fasting
6. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
7. Serum immunoreactive leptin concentrations in normal-weight and obese humans
8. Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates
9. Effects of gender, body composition, and menopause on plasma concentrations of leptin
10. Gender differences in plasma leptin concentration
11. Nocturnal rise of leptin in normal prepubertal and pubertal children and in patients with perinatal stalk-transection syndrome
12. Diurnal and ultradian rhythmicity of plasma leptin: Effects of gender and adiposity
13. Effect of obesity on estradiol level and its relationship to leptin, bone maturation, and bone mineral density in children
14. Sex differences in circulating human leptin pulse amplitude: Clinical implications
15. Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects
16. Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin
17. Leptin and aging: Correlation with endocrine changes in male and female healthy adult populations of different body weights
18. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men
19. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals
20. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: Dexamethasone and estradiol stimulate leptin release in women, but not in men
21. Estrogen increases in vivo leptin production in rats and human subjects
22. Circulating leptin in women: A longitudinal study in the menstrual cycle and during pregnancy
23. Relationship between leptin and estrogens in healthy women
24. Changes in plasma leptin during the menstrual cycle
25. Sexual dimorphism in plasma leptin concentrations
26. Leptin concentrations in women in the San Antonio Heart Study: Effect of menopausal status and postmenopausal hormone replacement therapy
27. Serum leptin levels in postmenopausal women: Effects of transdermal hormone replacement therapy
28. Serum leptin concentration in women: Effect of age, obesity, and estrogen administration
29. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women
30. Leptin in postmenopausal women: Influence of hormone therapy, insulin and fat distribution
31. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women
32. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy
33. Effects of short term hormone replacement on serum leptin levels in postmenopausal women
34. Effects of administration of 17β-oestradiol on serum leptin levels in healthy postmenopausal women
35. Assessment of fat-free mass using bioelectrical impedance measurements of the human body
36. The effect of transdermal 17 β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration
37. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: Its relationships with body fat, visceral adiposity, and age in women
38. Leptin receptor 5′ untraslated regions in the rat relative abundance, genomic organization and relation to putative response elements
39. Effect of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The postmenopausal estrogen/progestin interventions (PEPI) Trial
40. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women
41. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women
42. Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause
43. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulinsensitive and insulin-resistant Pima Indians
44. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans
45. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
46. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM
47. Metabolic fuels and reproduction in female mammals
48. Food intake and the menstrual cycle: A retrospective analysis, with implications for appetite research